Drug Type Small molecule drug |
Synonyms |
Mechanism β1-adrenergic receptor agonists(Beta-1 adrenergic receptor agonists), β3-adrenergic receptor agonists(Beta-3 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H26F2N2O5S |
InChIKeyXWLVOJZVWRCRMD-OFNKIYASSA-N |
CAS Registry170686-10-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 3 | US | - | |
Diabetes Mellitus, Type 2 | Phase 1 | US | - |